SCHEMBL22619002

SCHEMBL22619002

O=S(=O)(Nc1cccc(I)c1)c1cnc[nH]1

nearest known ligand 0.71

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
LMNA P02545 1/20 0.71
KMT2A Q03164 4/20 0.53
SMN1; SMN2 Q16637 2/20 0.46
NPSR1 Q6W5P4 1/20 0.44
ADRA2A P08913 1/20 0.42
ADRA1A P35348 1/20 0.42
PTGS1 P23219 1/20 0.41
PTGS2 P35354 1/20 0.41
TSHR P16473 1/20 0.40
CYP3A4 P08684 1/20 0.38
CYP2C9 P11712 1/20 0.38
CYP2C19 P33261 1/20 0.38
HTR6 P50406 1/20 0.38
MEN1 O00255 1/20 0.38
ALDH1A1 P00352 1/20 0.38
POLB P06746 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22618999 0.78 LMNA (0.43) LMNAPTGS1PTGS2CYP3A4CYP2C9
SCHEMBL22928009 0.76 LMNA (0.61) LMNAKMT2ASMN1; SMN2NPSR1ADRA2A
SCHEMBL22619000 0.75 LMNA (0.41) LMNAKMT2APTGS1PTGS2CYP3A4
SCHEMBL7595633 0.73 LMNA (0.74) LMNAKMT2ASMN1; SMN2NPSR1TSHR
SCHEMBL22618989 0.72 HPGD (0.43) LMNAKMT2ASMN1; SMN2PTGS1PTGS2
SCHEMBL22618998 0.72 CYP19A1 (0.43) LMNAKMT2APTGS1PTGS2TSHR
SCHEMBL15314389 0.72 KMT2A (0.65) KMT2ASMN1; SMN2PTGS1PTGS2TSHR
SCHEMBL22619045 0.71 HTR6 (0.46) KMT2APTGS1PTGS2HTR6MEN1
SCHEMBL22619087 0.71 EDNRA (0.44) LMNAKMT2APTGS1PTGS2CYP3A4
SCHEMBL1975871 0.71 LMNA (0.54) LMNAKMT2ASMN1; SMN2MEN1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3733670-A1 TETRAHYDROPYRROLE COMPOUND, PREPARATION METHOD THEREFOR, PHARMACEUTICAL COMPOSITION CONTAINING SAME, AND USE THEREOF Mediconns (Shanghai) Biopharmaceutical Co., Ltd (CN) 2020-11-04 EP disclosed